COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

Search

Hims & Hers Health Inc

Cerrado

SectorConsumo defensivo

16.63 -3.48

Resumen

Variación precio

24h

Actual

Mínimo

16.63

Máximo

17.61

Métricas clave

By Trading Economics

Ingresos

-27M

16M

Ventas

54M

599M

P/B

Media del Sector

36.472

33.023

Margen de beneficio

2.633

Empleados

1,637

EBITDA

-7.3M

30M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+70.46% upside

Dividendos

By Dow Jones

Próximas Ganancias

23 feb 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-5.6B

4.4B

Apertura anterior

20.11

Cierre anterior

16.63

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

124 / 133 Clasificación en Consumer defensive

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Hims & Hers Health Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

9 feb 2026, 09:37 UTC

Principales Movimientos del Mercado

Novo Nordisk Shares Jump After Hims & Hers Scraps Plan For Copycat Weight-Loss Pill

5 ago 2025, 00:05 UTC

Acciones populares

Stocks to Watch: Palantir Technologies, Hims & Hers Health, Vertex Pharmaceuticals, Kyndryl

29 abr 2025, 12:54 UTC

Principales Movimientos del Mercado

Hims & Hers Rallies After Novo Nordisk Deal on Wegovy

4 abr 2025, 22:38 UTC

Acciones populares

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

1 abr 2025, 23:15 UTC

Principales Movimientos del Mercado

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

25 feb 2025, 15:33 UTC

Principales Movimientos del Mercado

Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs

9 feb 2026, 17:41 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9 feb 2026, 17:31 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9 feb 2026, 15:15 UTC

Ganancias

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Valaris, Monday.com, Cleveland-Cliffs, and More -- Barrons.com

9 feb 2026, 15:07 UTC

Acciones populares

Stocks to Watch Monday: Novo Nordisk, Hims & Hers, Apollo -- WSJ

9 feb 2026, 13:13 UTC

Ganancias

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Kroger, Nvidia, Monday.com, and More -- Barrons.com

2 nov 2025, 10:30 UTC

Adquisiciones, fusiones, absorciones

Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk -- Heard on the Street -- WSJ

22 oct 2025, 21:25 UTC

Ganancias

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

5 ago 2025, 20:44 UTC

Ganancias

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 ago 2025, 18:17 UTC

Ganancias

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 ago 2025, 17:26 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Hims & Hers Had a Tough Quarter. Weight-Loss Drugs Are Only One Problem. -- Barrons.com

5 ago 2025, 15:25 UTC

Ganancias

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 ago 2025, 11:27 UTC

Ganancias

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 ago 2025, 10:55 UTC

Ganancias

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 ago 2025, 10:36 UTC

Ganancias

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

29 jul 2025, 16:55 UTC

Ganancias

The Obesity Bubble Has Finally Burst. Novo Nordisk Shares Drop 21%. -- Barrons.com

24 jun 2025, 10:26 UTC

Charlas de Mercado

Novo Nordisk Sends Clear Message on Copycat Drugs -- Market Talk

3 jun 2025, 15:03 UTC

Adquisiciones, fusiones, absorciones

Hims & Hers Seeks Growth in Europe as Weight-Loss Business Shifts -- Barrons.com

7 may 2025, 13:56 UTC

Ganancias

Novo Nordisk Stock Jumps After Earnings. Compounding Market's Growth Took it By Surprise -- Barrons.com

6 may 2025, 14:24 UTC

Ganancias

Hims & Hers Stock Is Higher After Earnings. The Sales Outlook Looks Low. -- Barrons.com

30 abr 2025, 09:30 UTC

Principales Noticias

Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ

2 abr 2025, 16:53 UTC

Principales Noticias

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom -- Analysis

19 mar 2025, 15:54 UTC

Principales Noticias

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

21 feb 2025, 23:20 UTC

Ganancias

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

Comparación entre iguales

Cambio de precio

Hims & Hers Health Inc Esperado

Precio Objetivo

By TipRanks

70.46% repunte

Estimación a 12 meses

Media 32.95 USD  70.46%

Máximo 60 USD

Mínimo 16.5 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Hims & Hers Health Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

12 ratings

3

Comprar

6

Mantener

3

Vender

Puntuación técnica

By Trading Central

36.685 / 52.35Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

124 / 133 Clasificación en Consumo defensivo

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
help-icon Live chat